Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
{{output}}
The dismal prognosis of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) prompted recent advances in the field of therapeutic approaches beyond cytotoxic cancer therapy. In recent years, the deeper and increasing knowledge on the genomi... ...
